CHRISTOPHER PATUSKY - 17 Aug 2022 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
Director
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Issuer symbol
UTHR
Transactions as of
17 Aug 2022
Net transactions value
-$436,995
Form type
4
Filing time
18 Aug 2022, 16:30:13 UTC
Previous filing
08 Jul 2022
Next filing
18 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $95,850 +1,500 +89% $63.90 3,180 17 Aug 2022 Direct F1
transaction UTHR Common Stock Disposed to Issuer $332,445 -1,500 -47% $221.63 1,680 17 Aug 2022 Direct F1
transaction UTHR Common Stock Options Exercise $132,045 +1,500 +89% $88.03 3,180 17 Aug 2022 Direct
transaction UTHR Common Stock Disposed to Issuer $332,445 -1,500 -47% $221.63 1,680 17 Aug 2022 Direct
holding UTHR Common Stock 1,200 17 Aug 2022 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Share Tracking Award Options Exercise $0 -1,500 -100% $0.000000* 0 17 Aug 2022 Common Stock 1,500 $63.90 Direct F1
transaction UTHR Share Tracking Award Options Exercise $0 -1,500 -12% $0.000000 11,500 17 Aug 2022 Common Stock 1,500 $88.03 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.
F2 Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.